hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse
Clinical trial NCT02960594 · COMPLETED
Trial details
- NCT number
- NCT02960594
- Sponsor
- Inovio Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2018-11-09
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.